Related Experiment Video
Updated: Jun 20, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Pre- and postcaptopril renal scintigraphy as a screening test for renovascular hypertension in children
Sameh Abdulsamea1, Peter Anderson, Lorenzo Biassoni
1Department of Paediatric Nephrology, Benha University Hospital, Benha, Egypt.
Insights
Pre- and postcaptopril renal scintigraphy showed limited accuracy in predicting renovascular disease (RVD) in children. The imaging technique demonstrated low sensitivity and negative predictive value for diagnosing RVD in pediatric patients.
Area of Science:
- Pediatric Nephrology
- Diagnostic Imaging
- Nuclear Medicine
Background:
- Renovascular disease (RVD) is a significant cause of secondary hypertension in children.
- Accurate diagnosis of RVD is crucial for timely intervention and management.
- Captopril renography is a non-invasive imaging technique used to assess renal artery stenosis.
Purpose of the Study:
- To evaluate the diagnostic performance of pre- and postcaptopril renal scintigraphy in predicting renovascular disease (RVD) in a pediatric population.
- To determine the sensitivity, specificity, and predictive values of this imaging modality for RVD detection.
Main Methods:
- Retrospective review of medical records and radiology reports of hypertensive children who underwent both pre- and postcaptopril renal scintigraphy.
- Scintigraphy utilized technetium-99m dimercaptosuccinic acid (DMSA) and/or technetium-99m mercaptoacetyltriglycine (MAG3).
- Digital subtraction angiography (DSA) served as the gold standard for RVD confirmation.
Main Results:
- A total of 81 children (aged 1-18 years) were included, with 62% diagnosed with RVD.
- The isotope study accurately diagnosed RVD in 47% of confirmed cases, with eight false positives.
- Sensitivity was 48%, specificity 73%, positive predictive value 76%, and negative predictive value 51%.
Conclusions:
- Pre- and postcaptopril renal scintigraphy demonstrated suboptimal accuracy in predicting renovascular disease in children.
- The low sensitivity and negative predictive value suggest this method is unreliable for excluding RVD in pediatric hypertension.
- Further investigation into more accurate diagnostic tools for pediatric RVD is warranted.
Abstract:
We studied the ability of pre- and postcaptopril renal scintigraphy to predict renovascular disease (RVD) in children. Retrospective review of medical notes and radiology reports of all hypertensive children who had had both pre- and postcaptopril renal scintigraphy with [(99m)Tc] dimercaptosuccinic acid (DMSA) and/or [(99m)Tc] mercaptoacetyltriglycine (MAG3) and digital subtraction angiography (DSA). 81 children aged 1-18 (median 10) years were studied with 62% (51) having a diagnosis of RVD. Main renal artery disease, intrarenal disease, and both main and intrarenal artery disease were present in 25, 14, and 12 patients respectively. The isotope study accurately diagnosed RVD, confirmed by DSA, in 47% (24 of 51) children, with eight false positive studies. The sensitivity, specificity, and positive and negative predictive values of the isotope study to predict RVD were 48%, 73%, 76%, and 51%, respectively. Pre- and postcaptopril renal scintigraphy was unable to predict RVD in children.
Related Concept Videos
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies II: Ultrasonography
Imaging Studies III: Computed Tomography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies I: Kidney, Ureter, and Bladder Studies

